Knocking out Fkbp51 decreases CCl 4 -induced liver injury through enhancement of mitochondrial function and Parkin activity.
Bin QiuZhaohui ZhongLongyu DouYuxue XuYi ZouKorri WeldonJun WangLingling ZhangMing LiuKent E WilliamsJohn Paul SpenceRichard L BellZhao LaiWeidong YongTiebing LiangPublished in: Cell & bioscience (2024)
Downregulation of FKBP51 represents a promising therapeutic target for liver disease treatment.